X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (124355) 124355
Patent (14358) 14358
Newspaper Article (2786) 2786
Newsletter (730) 730
Book Chapter (542) 542
Magazine Article (424) 424
Book / eBook (184) 184
Transcript (66) 66
Conference Proceeding (55) 55
Trade Publication Article (52) 52
Dissertation (47) 47
Web Resource (31) 31
Book Review (24) 24
Publication (19) 19
Government Document (12) 12
Reference (7) 7
Report (3) 3
Streaming Video (3) 3
Data Set (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (79147) 79147
animals (46306) 46306
enzymes (39966) 39966
male (38596) 38596
female (30251) 30251
biochemistry (20547) 20547
pharmacology & pharmacy (18922) 18922
angiotensin-converting enzyme inhibitors - therapeutic use (18592) 18592
proteins (18564) 18564
mice (18380) 18380
microbiology (17715) 17715
chemistry (17622) 17622
middle aged (17615) 17615
enzyme inhibitors - pharmacology (16234) 16234
enzymology (15505) 15505
rats (15045) 15045
wine (14414) 14414
beer (14386) 14386
vinegar (14368) 14368
metallurgy (14364) 14364
mutation or genetic engineering (14358) 14358
spirits (14358) 14358
enzyme inhibitors - therapeutic use (14041) 14041
aged (13992) 13992
human necessities (13680) 13680
hygiene (13679) 13679
medical or veterinary science (13648) 13648
research (13482) 13482
preparations for medical, dental, or toilet purposes (13400) 13400
adult (13309) 13309
cancer (12907) 12907
specific therapeutic activity of chemical compounds ormedicinal preparations (12573) 12573
oncology (12301) 12301
enzyme-linked immunosorbent assay (12166) 12166
apoptosis (12073) 12073
analysis (12066) 12066
culture media (11983) 11983
expression (11940) 11940
compositions thereof (11848) 11848
microorganisms or enzymes (11848) 11848
propagating, preserving or maintaining microorganisms (11848) 11848
biochemistry & molecular biology (11499) 11499
research article (11341) 11341
organic chemistry (11316) 11316
peptides (10693) 10693
medicine (10577) 10577
health aspects (10395) 10395
cell biology (10284) 10284
gene expression (10242) 10242
inflammation (9548) 9548
physiological aspects (9480) 9480
metabolism (9196) 9196
multidisciplinary sciences (9171) 9171
kinases (9108) 9108
rodents (8832) 8832
oxidative stress (8663) 8663
care and treatment (8493) 8493
hypertension - drug therapy (8210) 8210
activation (7886) 7886
inhibition (7866) 7866
science (7827) 7827
treatment outcome (7817) 7817
hypertension (7783) 7783
signal transduction (7347) 7347
neurosciences (7314) 7314
cell line, tumor (7290) 7290
cardiac & cardiovascular systems (7236) 7236
studies (7151) 7151
risk factors (6931) 6931
dose-response relationship, drug (6722) 6722
disease models, animal (6659) 6659
phosphorylation (6646) 6646
immunology (6396) 6396
biology (6369) 6369
drug therapy (6170) 6170
disease (5946) 5946
mortality (5839) 5839
time factors (5786) 5786
antihypertensive agents - therapeutic use (5774) 5774
genetic aspects (5744) 5744
cells, cultured (5739) 5739
cells (5697) 5697
enzyme inhibitors (5685) 5685
medicine, research & experimental (5638) 5638
cytokines (5615) 5615
in-vitro (5537) 5537
inhibitors (5527) 5527
physiology (5451) 5451
diabetes (5347) 5347
rats, sprague-dawley (5346) 5346
compositions or test papers therefor (5287) 5287
condition-responsive control in microbiological orenzymological processes (5287) 5287
measuring or testing processes involving enzymes, nucleicacids or microorganisms (5287) 5287
processes of preparing such compositions (5287) 5287
medicine & public health (5160) 5160
tumors (5157) 5157
mutation (5143) 5143
drug therapy, combination (4926) 4926
medical research (4910) 4910
physics (4852) 4852
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (87) 87
Online Resources - Online (25) 25
Collection Dvlpm't (Acquisitions) - Vendor file (16) 16
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
UofT at Mississauga - Stacks (6) 6
Chemistry (A D Allen) - Stacks (4) 4
UofT at Scarborough - Stacks (4) 4
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Not Returned (1) 1
Gerstein Science - Theses (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (137644) 137644
French (5750) 5750
German (3676) 3676
Japanese (1653) 1653
Russian (778) 778
Chinese (721) 721
Spanish (679) 679
Korean (326) 326
Italian (311) 311
Portuguese (269) 269
Polish (239) 239
Danish (179) 179
Hungarian (171) 171
Norwegian (125) 125
Czech (111) 111
Finnish (105) 105
Dutch (94) 94
Swedish (90) 90
Slovak (39) 39
Croatian (35) 35
Bulgarian (34) 34
Hebrew (32) 32
Slovenian (30) 30
Romanian (29) 29
Ukrainian (29) 29
Serbian (26) 26
Turkish (25) 25
Lithuanian (21) 21
Greek (11) 11
Arabic (6) 6
Estonian (6) 6
Icelandic (3) 3
Indonesian (2) 2
Latvian (2) 2
Afrikaans (1) 1
Bosnian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary prevention medications in these communities... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2008, Volume 359, Issue 12, pp. 1238 - 1251
In this large clinical trial, aspirin plus extended-release dipyridamole was found to have an efficacy similar to that of clopidogrel in the prevention of... 
ACTIVE CONTROLLED-TRIALS | HIGH-RISK PATIENTS | TICLOPIDINE | TRANSIENT ISCHEMIC ATTACK | DOUBLE-BLIND | PREVENTION | RANDOMIZED CONTROLLED-TRIAL | ARTERIAL ORIGIN ESPRIT | CEREBRAL-ISCHEMIA | UMCG Approved | NON-INFERIORITY TRIALS | ISSUES | MEDICINE, GENERAL & INTERNAL | PLACEBO | DESIGN | WARFARIN | REGIMENS | Myocardial Infarction - epidemiology | Benzoates - therapeutic use | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Risk | Secondary Prevention | Aspirin - administration & dosage | Vascular Diseases - mortality | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Dipyridamole - adverse effects | Female | Stroke - epidemiology | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Dipyridamole - therapeutic use | Benzimidazoles - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Brain Ischemia - epidemiology | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Ischemia - prevention & control | Factor Analysis, Statistical | Stroke - drug therapy | Ticlopidine - analogs & derivatives | Aged | Hemorrhage - chemically induced | Delayed-Action Preparations | Stroke (Disease) | Aspirin | Usage | Care and treatment | Dipyridamole | Clopidogrel | Health aspects | Stroke | Index Medicus | Abridged Index Medicus | Recurrence | Brain Ischemia | Benzimidazoles | Follow-Up Studies | Neurons and Cognition | Cognition | Hemorrhage | Drug Delivery Systems | Life Sciences | Angiotensin II Type 1 Receptor Blockers | Angiotensin-Converting Enzyme Inhibitors | Vascular Diseases | Mental Status Schedule | Retrospective Studies | Severity of Illness Index | Disability Evaluation | Benzoates | Drug Administration Schedule | International Cooperation | Ticlopidine | Myocardial Infarction | Platelet Aggregation Inhibitors | Santé publique et épidémiologie | Original | Dipyridamole/adverse effects/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Recurrence/prevention & control | Benzoates/therapeutic use | Brain Ischemia/epidemiology/prevention & control | MEDICIN OCH HÄLSOVETENSKAP | Platelet Aggregation Inhibitors/administration & dosage/adverse | Combination | MEDICAL AND HEALTH SCIENCES | Aspirin/administration & dosage/adverse effects | Myocardial Infarction/epidemiology | Factor Analysis | Benzimidazoles/therapeutic use | Drug Therapy | Ticlopidine/adverse effects/analogs & derivatives/therapeutic use | effects/therapeutic use | Vascular Diseases/mortality | Hemorrhage/chemically induced | Stroke/drug therapy/epidemiology/prevention & control | Statistical | Kaplan-Meiers Estimate
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 146, Issue 3, pp. 736 - 743.e1
Journal Article
Drugs, ISSN 0012-6667, 2003, Volume 63, Issue 19, pp. 1973 - 1998
... with therapeutic potential.These new drugs include aids to smoking cessation (e.g. bupropion) and improvements to existing therapies, for example long-acting rather than short-acting bronchodilators, as well as combination therapy... 
Tumour necrosis factor antagonists, therapeutic us | Mitogen activated protein kinase inhibitors, thera | Beta 2 adrenoceptor agonists, therapeutic use | Chronic obstructive pulmonary disease, treatment | Acetylcholine receptor antagonists, therapeutic us | Smoking withdrawal, treatment | Research and development | Nitric oxide synthase inhibitors, therapeutic use | Leukotriene B4 antagonists, therapeutic use | Interleukin 10, therapeutic use | Leucocyte elastase inhibitors, therapeutic use | Phosphodiesterase inhibitors, therapeutic use | Cyclo oxygenase 2 inhibitors, therapeutic use | Protease inhibitors, therapeutic use | Adenosine A2 receptor agonists, therapeutic use | Mucolytics, therapeutic use | Anti inflammatories, therapeutic use | Antioxidants, therapeutic use | Chemokine antagonists, therapeutic use | Sibenadet, therapeutic use | Adhesion molecule antagonists, therapeutic use | Metalloproteinase inhibitors, therapeutic use | NF kappa B Decoy, therapeutic use | Bronchodilators, therapeutic use | Smoking cessation therapies, therapeutic use | Theophylline, therapeutic use | Neurokinin antagonists, therapeutic use | Retinoids, therapeutic use | Corticosteroids, therapeutic use | P2Y2 receptor agonists, therapeutic use | Cysteine protease inhibitors, therapeutic use | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | KAPPA-B ACTIVATION | NEUTROPHIL ELASTASE INHIBITORS | NITRIC-OXIDE SYNTHASE | PROTEIN-KINASE INHIBITOR | ACUTE LUNG INJURY | PHARMACOLOGY & PHARMACY | ALPHA-CONVERTING-ENZYME | TOXICOLOGY | MATRIX-METALLOPROTEINASE INHIBITOR | TRANS-RETINOIC ACID | T-CELL | SUPEROXIDE-DISMUTASE | Clinical Trials as Topic | Pulmonary Disease, Chronic Obstructive - physiopathology | Humans | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Journal Article